These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31131437)

  • 1. Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.
    Magliocco G; Thomas A; Desmeules J; Daali Y
    Clin Pharmacokinet; 2019 Nov; 58(11):1373-1391. PubMed ID: 31131437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative Sampling Strategies for Cytochrome P450 Phenotyping.
    De Kesel PM; Lambert WE; Stove CP
    Clin Pharmacokinet; 2016 Feb; 55(2):169-84. PubMed ID: 26239501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo.
    Sychev DA; Ashraf GM; Svistunov AA; Maksimov ML; Tarasov VV; Chubarev VN; Otdelenov VA; Denisenko NP; Barreto GE; Aliev G
    Drug Des Devel Ther; 2018; 12():1147-1156. PubMed ID: 29780235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro.
    Cheng HX; Lu YY; Wang X; Ren H; Li Q; Wang SM; Ding Y; Lou YQ; Zhang GL
    Eur J Pharm Sci; 2018 Oct; 123():241-248. PubMed ID: 30010032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To Genotype or Phenotype for Personalized Medicine? CYP450 Drug Metabolizing Enzyme Genotype-Phenotype Concordance and Discordance in the Ecuadorian Population.
    De Andrés F; Terán S; Hernández F; Terán E; LLerena A
    OMICS; 2016 Dec; 20(12):699-710. PubMed ID: 27849442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
    de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
    OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case-control pharmacokinetic study.
    Gravel S; Chiasson JL; Dallaire S; Turgeon J; Michaud V
    BMJ Open; 2018 Feb; 8(2):e020922. PubMed ID: 29439084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach.
    de Andrés F; Terán S; Bovera M; Fariñas H; Terán E; LLerena A
    OMICS; 2016 Feb; 20(2):88-96. PubMed ID: 26600202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive components of Glycyrrhiza uralensis mediate drug functions and properties through regulation of CYP450 enzymes.
    Chen H; Zhang X; Feng Y; Rui W; Shi Z; Wu L
    Mol Med Rep; 2014 Sep; 10(3):1355-62. PubMed ID: 24939038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of cytochrome P450 isoforms to gliquidone metabolism in rats and human.
    He F; Li Y; Zeng C; Xia C; Xiong Y; Zhang H; Huang S; Liu M
    Xenobiotica; 2014 Mar; 44(3):229-34. PubMed ID: 23987740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Robust Machine Learning Framework Built Upon Molecular Representations Predicts CYP450 Inhibition: Toward Precision in Drug Repurposing.
    Ouzounis S; Panagiotopoulos V; Bafiti V; Zoumpoulakis P; Cavouras D; Kalatzis I; Matsoukas MT; Katsila T
    OMICS; 2023 Jul; 27(7):305-314. PubMed ID: 37406257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.
    Wijnen PA; Op den Buijsch RA; Drent M; Kuijpers PM; Neef C; Bast A; Bekers O; Koek GH
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():211-9. PubMed ID: 18081664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of water extract from traditional Chinese medicines Rehmannia glutinosa, Scrophularia ningpoensis, Asparagus cochinchinensis and Ophiopogon japonicas on contents of CYP450 and activities of CYP3A, CYP2E1 and CYP1A2 in rat].
    Wu B; Liu P; Gao Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2710-4. PubMed ID: 22242435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450: genetic polymorphism and drug interactions.
    Belpaire FM; Bogaert MG
    Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cytochrome P450 enzymes involved in the oxidative metabolism of xenobiotics: Focus on the regulation of gene expression and enzyme activity.
    Pang X; Tang C; Guo R; Chen X
    Pharmacol Ther; 2022 May; 233():108020. PubMed ID: 34637840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modern approaches for the phenotyping of cytochrome P450 enzymes in children.
    Magliocco G; Daali Y
    Expert Rev Clin Pharmacol; 2020 Jul; 13(7):671-674. PubMed ID: 32500746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.